Minerva Neurosciences, Inc. (NERV) stock
NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.16−0.04 (-1.82%)
Close on Nov 17, 2026Market cap $103.14MP/E –Yield –
Minerva Neurosciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Minerva Neurosciences's total debt was $1.33M at Jun 30, 2017. For fiscal 2016 it was $3.84M, down 54.8% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $3.84M | -54.8% |
| FY2015 | Dec 31, 2015 | $8.50M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2017 | Jun 30, 2017 | $1.33M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.60M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.84M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.05M | – |
See a number that looks wrong?